Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir

BACKGROUND: Until now, no risk score could predict hepatocellular carcinoma (HCC) in nucleos(t)ide analog (NA)-treated Asian patients. METHODS: We enrolled 1325 NA-naïve chronic hepatitis B patients with entecavir monotherapy for >12 months, with 883 and 442 patients randomly assigned to the deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chien-Hung, Lee, Chuan-Mo, Lai, Hsueh-Chou, Hu, Tsung-Hui, Su, Wen-Pang, Lu, Sheng-Nan, Lin, Chia-Hsin, Hung, Chao-Hung, Wang, Jing-Houng, Lee, Mei-Hsuan, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696194/
https://www.ncbi.nlm.nih.gov/pubmed/29190928
http://dx.doi.org/10.18632/oncotarget.21369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696194/
https://www.ncbi.nlm.nih.gov/pubmed/29190928
http://dx.doi.org/10.18632/oncotarget.21369

Ejemplares similares